Markets:

Overview

News

Currencies

International

Treasuries

Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

4.130 +0.060 (+1.47%)

Streaming Delayed Price Updated: 10:10 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sana Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

April 09, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

SANA Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP for Information on How to Lead the Class Action Against Sana Biotechnology, Inc.

April 07, 2025

From Robbins LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA

April 07, 2025

From Pomerantz LLP

Via GlobeNewswire

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs ↗

January 10, 2025

Via Benzinga

Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA

April 06, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA

April 03, 2025

From Pomerantz LLP

Via GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA

April 02, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

April 02, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday ↗

April 02, 2025

Via Benzinga

Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1 ↗

April 01, 2025

Three small-cap stocks have intrigued Stocktwits users the most among the biotech sector this year, thanks to promising data from clinical trials and a leadership shuffle.

Via Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA

March 30, 2025

From Pomerantz LLP

Via GlobeNewswire

SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

March 27, 2025

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

March 27, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action Lawsuit Against SANA

March 26, 2025

From Robbins LLP

Via GlobeNewswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA

March 26, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA

March 26, 2025

From Pomerantz LLP

Via GlobeNewswire

Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

March 24, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 23, 2025

From The Schall Law Firm

Via Business Wire

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

March 17, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

February 24, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why ↗

January 31, 2025

Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.

Via Stocktwits

There May Still Be Time to Get in on These 3 Trending Biotechs

January 20, 2025

Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.

Via MarketBeat

Topics ETFs Economy

Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type 1 Diabetes, CS Diagnostics (OTCQB: CSDX) Cancer Therapy – CURR, TPET, PRSO, PNPN.V, EONR – Plus More Stocks Under $2 Inside See Now!

January 08, 2025

Via AB Newswire

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 08, 2025

Via Benzinga

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 08, 2025

From Sana Biotechnology, Inc

Via GlobeNewswire

Crude Oil Down 1%; US Weekly Jobless Claims Decline ↗

January 08, 2025

Via Benzinga

AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday ↗

January 08, 2025

Via Benzinga

US Stocks Down; Acuity Brands Posts Weak Revenue ↗

January 08, 2025

Via Benzinga

Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why ↗

January 08, 2025

Sana Biotechnology's first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes without immunosuppression.

Via Benzinga

Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket ↗

January 08, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.